Status:
UNKNOWN
Validation of a Smartphone Application for the Assessment of Patients With Mild Cognitive Impairment: MemScreen
Lead Sponsor:
MemScreen
Conditions:
Cognitive Impairment
Alzheimer Disease
Eligibility:
All Genders
40+ years
Brief Summary
The clinical evaluation of a patient with a cognitive complaint requires neuropsychological tests, evaluating the integrity of memory and other cognitive functions. The initial evaluation is made mos...
Detailed Description
Characteristics of MemScreen : * Smartphone / tablet application developed by the Cognitive Neurology Center at Lariboisière - Fernand Widal Hospital to explore a patient with a cognitive disorder. *...
Eligibility Criteria
Inclusion
- Major patients followed in memory clinic.
- Performing a neuropsychological assessment less than 6 months old.
- No visual or motor deficiency impeding the use of a digital tablet.
Exclusion
- None.
Key Trial Info
Start Date :
January 17 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2020
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03811184
Start Date
January 17 2019
End Date
June 1 2020
Last Update
August 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Neurologie Cognitive Hôpital Fernand Widal
Paris, France, 75010